MON-902 Etomidate - an Under Utilized but Safe and Efficacious Drug to Treat Acute Severe Cushing’s Syndrome- Case Reports of Ectopic ACTH Syndrome from Neuroendocrine Malignancies

Background: Intravenous etomidate infusion, in non-hypnotic doses, rapidly lowers cortisol levels by blocking 11-beta hydroxylation of deoxycortisol to inhibit cortisol production. It is an underutilized drug due to concerns of excess sedation and ICU monitoring. Clinical Case 1: A 44 year-old femal...

Descripción completa

Detalles Bibliográficos
Autores principales: Cherian, Elena Thampy, Naik, Sapna, Cillo, Marc, Shah, Neel L, Gutierrez, Absalon Dennis, Guttenberg, Katie, Orlander, Philip R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207773/
http://dx.doi.org/10.1210/jendso/bvaa046.1381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7207773/
http://dx.doi.org/10.1210/jendso/bvaa046.1381

Ejemplares similares